Accuray (ARAY) vs iTonic (ITOC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iTonic (ITOC) has outperformed Accuray (ARAY) over the past year, losing 64.2% versus a loss of 85.6%. iTonic is the larger company by market cap ($29.4 million vs $28.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARAY | ITOC |
|---|---|---|
| Share price | $0.2414 | $4.02 |
| Market cap | $28.83M | $29.41M |
| 1-day change | -4.74% | -3.13% |
| YTD return | -70.56% | -40.32% |
| 1-year return | -85.63% | -64.16% |
| 5-year return | -93.86% | — |
| EPS (TTM) | $-0.40 | $-4.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.10 | $18.40 |
| 52-week low | $0.22 | $3.42 |
| Distance from 52-week high | -88.50% | -78.15% |
| Analyst consensus | none | — |
| Average volume | 7.19M | 51.11K |
| Shares outstanding | 119.44M | 6.84M |
| Employees | 809 | 7 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ITOC has outperformed ARAY by 21.5 percentage points over the past year.
About Accuray
ARAY stock →Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.
Healthcare · Medical Devices · 809 employees
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Healthcare · Medical Devices · 7 employees
ARAY vs ITOC FAQ
Which is bigger, Accuray or iTonic?
iTonic (ITOC) is larger, with a market capitalization of $29.41M compared with $28.83M for Accuray (ARAY).
Which stock has performed better over the past year, ARAY or ITOC?
ITOC returned -64.16% over the past 12 months, compared with -85.63% for ARAY (price return, excluding dividends). Past performance does not predict future results.
Are Accuray and iTonic in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.